THOMAS E HOSHOUR
Osteopathic Medicine at Ditch Rd, Indianapolis, IN
License number
Florida 7567
Issued Date
Oct 8, 1997
Effective Date
Sep 1, 2006
Expiration Date
Mar 31, 2004
Category
Health Care
Type
Osteopathic Physician
Address
Address
8705 Ditch Rd, Indianapolis, IN 46260
Phone
(317) 856-6526
Personal information
See more information about THOMAS E HOSHOUR at radaris.comName
Address
Phone
6 Bayview Dr, Cicero, IN 46034
27 Linwood Ave, Indianapolis, IN 46201
7305 37Th St, Indianapolis, IN 46226
7305 37Th St, Indianapolis, IN 46226
6 Bayview Dr, Cicero, IN 46034
Professional information
See more information about THOMAS E HOSHOUR at trustoria.com
Thomas Hoshour - Indianapolis, IN
Thomas Hoshour - Indianapolis, IN
Work:
Addiction Buster, LLC
Research Content Specialist State of Indiana
Addiction Medicine Physician Emergency Medicine - Indianapolis, IN
Family Practice Physician
Research Content Specialist State of Indiana
Addiction Medicine Physician Emergency Medicine - Indianapolis, IN
Family Practice Physician
Education:
Indiana University
BA in Chemistry Midwestern University Chicago College of Osteopathic Medicine - Garden City, MI
Doctor of Osteopathic Medicine
BA in Chemistry Midwestern University Chicago College of Osteopathic Medicine - Garden City, MI
Doctor of Osteopathic Medicine
Methods For The Treatment Of Addictive Disease And Addiction To Chemical Substances And Addictive Behaviors Using A Formula Containing The Following Formulation: Mucuna Pruiens, N Acetyl L Cysteine, Magnesium Citrate
Methods For The Treatment Of Addictive Disease And Addiction To Chemical Substances And Addictive Behaviors Using A Formula Containing The Following Formulation: Mucuna Pruiens, N Acetyl L Cysteine, Magnesium Citrate
US Patent:
2009028, Nov 12, 2009
Filed:
May 7, 2008
Appl. No.:
12/151395
Inventors:
Thomas Eugene Hoshour - Indianapolis IN, US
International Classification:
A61K 36/00, A61P 25/30
US Classification:
424725
Abstract:
The invention is directed at the formulation of N Acetyl L Cysteine and Magnesium Citrate. This formulation augments dopamine in the striatal area of the human brain and stabilizes membranes by restoring normal neurotransmitter levels and decreasing endogenous catecholamines. These effects are beneficial in the short and long term treatment of addictive disease and addiction to chemical substances and addictive behaviors.